{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:56:13Z","timestamp":1777416973148,"version":"3.51.4"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,8,1]]},"DOI":"10.1093\/jac\/dki241","type":"journal-article","created":{"date-parts":[[2005,7,8]],"date-time":"2005-07-08T00:33:28Z","timestamp":1120782808000},"page":"365-371","source":"Crossref","is-referenced-by-count":57,"title":["Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models"],"prefix":"10.1093","volume":"56","author":[{"given":"D.","family":"Girard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Finegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. W.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E.","family":"Lame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,7,7]]},"reference":[{"key":"key\n\t\t\t\t20171010220921_B1","doi-asserted-by":"crossref","unstructured":"Reed MD, Blumer JL. Azithromycin: a critical review of the first azalide antibiotic and its role in pediatric practice. Pediatr Infect Dis J1977; 16: 1069\u201383.","DOI":"10.1097\/00006454-199711000-00013"},{"key":"key\n\t\t\t\t20171010220921_B2","doi-asserted-by":"crossref","unstructured":"Gordon EM, Blumer JL. Rationale for single and high dose treatment regimens with azithromycin. Pediatr Infect Dis J2004; 23: S102\u20137.","DOI":"10.1097\/01.inf.0000112523.95762.f5"},{"key":"key\n\t\t\t\t20171010220921_B3","unstructured":"Zithromax (azithromycin) [package insert]. New York: Pfizer Inc, 2002."},{"key":"key\n\t\t\t\t20171010220921_B4","doi-asserted-by":"crossref","unstructured":"Arguedas A, Loaiza C, Perez A et al. A pilot study of single-dose azithromycin versus three-day azithromycin or single-dose ceftriaxone for uncomplicated acute otitis media in children. Curr Ther Res Clin Exp2003; 64 Suppl A: A16\u2013A29.","DOI":"10.1016\/j.curtheres.2003.09.005"},{"key":"key\n\t\t\t\t20171010220921_B5","doi-asserted-by":"crossref","unstructured":"Block SL, Arrieta A, Seibel M et al. Single-dose (30 mg\/kg) azithromycin compared with 10-day amoxicillin\/clavulanate (45 mg\/kg\/per day) for the treatment of uncomplicated acute otitis media. Curr Ther Res Clin Exp2003; 64 Suppl A: A30\u2013A42.","DOI":"10.1016\/j.curtheres.2003.09.006"},{"key":"key\n\t\t\t\t20171010220921_B6","doi-asserted-by":"crossref","unstructured":"Arguedas A, Soley C, Guevara S et al. Clinical efficacy of single-dose azithromycin versus high-dose amoxicillin for the treatment of children with acute otitis media. In: Programs and Abstracts of the Pediatric Academic Societies Annual Meeting, San Francisco, CA, USA, 2004. Abstract 1894. American Pediatric Society, The Woodlands, TX, USA.","DOI":"10.1097\/01.inf.0000112524.71839.c6"},{"key":"key\n\t\t\t\t20171010220921_B7","doi-asserted-by":"crossref","unstructured":"Arguedas A, Loaiza C, Soley C. Single dose azithromycin for the treatment of uncomplicated otitis media. Pediatr Infect Dis J2004; 23 Suppl 2: S108\u201314.","DOI":"10.1097\/01.inf.0000112524.71839.c6"},{"key":"key\n\t\t\t\t20171010220921_B8","doi-asserted-by":"crossref","unstructured":"Rothermel CD. Single-dose azithromycin for acute otitis media: a pharmacokinetic\/pharmacodynamic rationale. Curr Ther Res Clin Exp2003; 64 Suppl A: A4\u2013A15.","DOI":"10.1016\/j.curtheres.2003.09.004"},{"key":"key\n\t\t\t\t20171010220921_B9","doi-asserted-by":"crossref","unstructured":"Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother1990; 25 Suppl A: 73\u201382.","DOI":"10.1093\/jac\/25.suppl_A.73"},{"key":"key\n\t\t\t\t20171010220921_B10","doi-asserted-by":"crossref","unstructured":"Gladue RP, Bright GM, Isaacson RE et al. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother1989; 33: 277\u201382.","DOI":"10.1128\/AAC.33.3.277"},{"key":"key\n\t\t\t\t20171010220921_B11","doi-asserted-by":"crossref","unstructured":"Hand WL, Hand DL. Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes. Int J Antimicrob Agents2001; 18: 419\u201325.","DOI":"10.1016\/S0924-8579(01)00430-7"},{"key":"key\n\t\t\t\t20171010220921_B12","unstructured":"Drusano GL, Craig WA. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. J Chemother1997; 9 Suppl 3: 38\u201344."},{"key":"key\n\t\t\t\t20171010220921_B13","doi-asserted-by":"crossref","unstructured":"Craig WA. The hidden impact of antibacterial resistance in respiratory tract infection. Re-evaluating current antibiotic therapy. Respir Med2001; 95 Suppl A: S12\u201319.","DOI":"10.1016\/S0954-6111(01)90023-X"},{"key":"key\n\t\t\t\t20171010220921_B14","unstructured":"National Committee for Clinical Laboratory Standards. Methods for Determining Bactericidal Activity of Antimicrobial Agents. Tentative Guideline M26-T. NCCLS, Villanova, PA, USA, 1992."},{"key":"key\n\t\t\t\t20171010220921_B15","doi-asserted-by":"crossref","unstructured":"Trudeau-Lame ME, Kalgutkar AS, LaFontaine M. Pharmacokinetics and metabolism of the reactive oxygen scavenger alpha-phenyl-N-tert-butylnitrone in the male Sprague\u2013Dawley rat. Drug Metab Dispos2003; 31: 147\u201352.","DOI":"10.1124\/dmd.31.2.147"},{"key":"key\n\t\t\t\t20171010220921_B16","doi-asserted-by":"crossref","unstructured":"Duong M, Simard M, Bergeron Y et al. Kinetic study of the inflammatory response in Streptococcus pneumoniae experimental pneumonia treated with the ketolide HMR 3004. Antimicrob Agents Chemother2001; 45: 252\u201362.","DOI":"10.1128\/AAC.45.1.252-262.2001"},{"key":"key\n\t\t\t\t20171010220921_B17","doi-asserted-by":"crossref","unstructured":"Dunn CH, Barradell LB. Azithromycin. A review of its pharmacological properties and use as a 3-day therapy in respiratory tract infections. Drugs1996; 51: 483\u2013505.","DOI":"10.2165\/00003495-199651030-00013"},{"key":"key\n\t\t\t\t20171010220921_B18","doi-asserted-by":"crossref","unstructured":"Guay D. Short-course antimicrobial therapy of respiratory tract infections. Drugs2003; 63: 2169\u201384.","DOI":"10.2165\/00003495-200363200-00002"},{"key":"key\n\t\t\t\t20171010220921_B19","doi-asserted-by":"crossref","unstructured":"Craig WA. Does the dose matter? Clin Infect Dis2003; 33 Suppl 3: S233\u20137.","DOI":"10.1086\/321854"},{"key":"key\n\t\t\t\t20171010220921_B20","doi-asserted-by":"crossref","unstructured":"Craig WA. Overview of newer antimicrobial formulations for overcoming pneumococcal resistance. Am J Med2004; 117 Suppl 3A: 16S\u201322S.","DOI":"10.1016\/j.amjmed.2004.07.004"},{"key":"key\n\t\t\t\t20171010220921_B21","doi-asserted-by":"crossref","unstructured":"Amsden GW, Gray CL. Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given as a single dose or over a 3 day period in healthy volunteers. J Antimicrob Chemother2001; 47: 61\u20136.","DOI":"10.1093\/jac\/47.1.61"},{"key":"key\n\t\t\t\t20171010220921_B22","unstructured":"Forrest A, Okusanya OO, Girard D et al. A novel approach to \u2018humanize\u2019 plasma drug concentration profiles for small animal models. Clin Exp Pharmacol Physiol2004; 21 Suppl: A52."},{"key":"key\n\t\t\t\t20171010220921_B23","doi-asserted-by":"crossref","unstructured":"Okusanya OO, Forrest A, Booker BM et al. Pharmacokinetics and pharmacodynamics of azithromycin in gerbils with Haemophilus influenzae middle ear infection. Clin Pharmacol Ther2005; 77: 89.","DOI":"10.1016\/j.clpt.2004.12.234"},{"key":"key\n\t\t\t\t20171010220921_B24","doi-asserted-by":"crossref","unstructured":"Girard AE, Cimochowski CR, Faiella JA. Correlation of increased azithromycin concentrations with phagocyte infiltration into sites of localized infection. J Antimicrob Chemother1996; 37 Suppl C: 9\u201319.","DOI":"10.1093\/jac\/37.suppl_C.9"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/56\/2\/365\/2492809\/dki241.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T07:56:04Z","timestamp":1626162964000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/56\/2\/365\/837428\/Enhanced-efficacy-of-singledose-versus-multidose"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,7]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,7,7]]},"published-print":{"date-parts":[[2005,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki241","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,8]]},"published":{"date-parts":[[2005,7,7]]}}}